Kura Oncology
KURA
152 hedge funds and large institutions have $1.25B invested in Kura Oncology in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 54 increasing their positions, 54 reducing their positions, and 29 closing their positions.
131% more call options, than puts
Call options by funds: $4.39M | Put options by funds: $1.9M
0% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 54
1.4% less ownership
Funds ownership: 102.07% → 100.66% (-1.4%)
11% less funds holding
Funds holding: 171 → 152 (-19)
11% less capital invested
Capital invested by funds: $1.41B → $1.25B (-$160M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
66% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$27.8M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$15.1M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$12.4M |
| 4 |
DM
Deerfield Management
New York
|
+$9.83M |
| 5 |
AG
Artal Group
Luxembourg
|
+$8.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$26.6M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$13.6M |
| 4 |
VA
VR Adviser
New York
|
-$12M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.4M |
KURA Hedge Fund Activity: Q3 2021 in Review
152 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2021, worth a combined $1.25B — down 11% from $1.41B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of KURA and 10 opened new positions — a net loss of 19 holders — while 54 trimmed existing stakes and 54 added.
The largest buyer was Invesco, adding an estimated $27.8M. The largest seller was Fidelity Investments, cutting an estimated $29.8M.
- 152 institutional investors held Kura Oncology (KURA) as of Q3 2021, down from 171 in Q2 2021.
- Funds reported $1.25B of Kura Oncology stock for Q3 2021, down 11% quarter-over-quarter.
- 10 funds opened new Kura Oncology positions in Q3 2021 and 29 closed out, a net change of -19 holders.
- The largest Kura Oncology buyer in Q3 2021 was Invesco, an estimated $27.8M added.
- The largest Kura Oncology seller in Q3 2021 was Fidelity Investments, an estimated $29.8M sold.
Based on aggregated 13F filings for Q3 2021.